Pharmacyclics Announces Date of Fiscal Year End 2011 Financial Results and Conference Call

Sep 08, 2011, 16:00 ET from Pharmacyclics

SUNNYVALE, Calif., Sept. 8, 2011 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer and immune mediated diseases, today announced that it will report financial results for the fourth fiscal quarter and fiscal year ended June 30, 2011 after the NASDAQ Market closes on Monday, September 12, 2011.  The company will conduct a conference call and an audio webcast at 4:30 p.m. EDT on the same day.

Fiscal Year End Quarter 2011 Conference Call and Webcast Details

Date: September 12, 2011

Time: 4:30 PM EDT

Listen via Internet: http://ir.pharmacyclics.com/events.cfm

Toll-free: +1-877-407-8133

International: +1-201-689-8040

Replay Number (Toll Free): 877-660-6853  

Replay Number (International): 201-612-7415

Replay Passcodes (both required for playback):

Account #: 286

Conference ID #: 378850

A webcast replay will be available on the Pharmacyclics website for 30 days.

About Pharmacyclics

Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medial healthcare needs; and to identify promising product candidates based on scientific development expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate.

Presently, Pharmacyclics has three product candidates in clinical development and several preclinical molecules in lead optimization. We are committed to high standards of ethics, scientific rigor, and operational efficiency as we move each of these programs to viable commercialization.

The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.

SOURCE Pharmacyclics



RELATED LINKS

http://www.pharmacyclics.com